Nabil K El Ayoubi, Ali Ismail, Georgio Sader, Nour Abi Chakra, Jad El Ahdab, Joseph Abboud, Samia J Khoury
{"title":"视网膜光学相干断层扫描纵向测量作为多发性硬化症的预后生物标志物:系统评价和荟萃分析。","authors":"Nabil K El Ayoubi, Ali Ismail, Georgio Sader, Nour Abi Chakra, Jad El Ahdab, Joseph Abboud, Samia J Khoury","doi":"10.1212/NXI.0000000000200416","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Optical coherence tomography (OCT) has emerged as a valuable marker for assessing inflammation and neuroaxonal degeneration in multiple sclerosis (MS). Although traditional markers such as brain atrophy and axonal loss are crucial for monitoring MS progression, their clinical application can be limited by various factors. This meta-analysis of longitudinal studies aims to assess the predictive value of OCT-derived retinal layer thickness thresholds for monitoring and predicting MS disease progression and cognitive decline.</p><p><strong>Methods: </strong>Our systematic review and meta-analysis followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A comprehensive systematic search was performed using electronic databases (PubMed, Embase, Web of Science, and Google Scholar) for longitudinal studies using Spectral Domain-OCT (SD-OCT) to assess retinal layer thickness and its predictive value for MS progression. Data were extracted on study design, OCT measurements, disability progression definitions, and clinical outcomes. We analyzed hazard ratios (HR) and odds ratios (OR) for associations between OCT-measured thresholds and disability progression, including physical and cognitive deterioration.</p><p><strong>Results: </strong>Our study included 14 longitudinal studies that met our inclusion criteria, 13 studies were included in our quantitative analysis, with a total of 3,683 participants. Baseline peripapillary retinal nerve fiber layer (pRNFL) thickness below 88 μm was significantly associated with increased risk of future disease progression and physical worsening measured by Expanded Disability Status Scale progression (HR = 2.376, <i>p</i> < 0.001; HR = 2.258, <i>p</i> < 0.001, respectively). The same was noted for ganglion cell-inner plexiform layer (GCIPL) thickness below 77 μm (HR = 2.751, <i>p</i> < 0.001 and HR = 2.66, <i>p</i> < 0.001, respectively). In addition, annualized rates of pRNFL thinning above 1.5 μm/y and GCIPL thinning above 1 μm/y also significantly predicted disease worsening (HR = 3.019, <i>p</i> = 0.005 and HR = 3.535, <i>p</i> < 0.001, respectively).</p><p><strong>Discussion: </strong>OCT-derived retinal layer thresholds, specifically a pRNFL thickness of ≤88 μm and a GCIPL thickness of ≤77 μm, are significantly associated with an increased risk of future MS disability progression. Furthermore, annual thinning rates of pRNFL >1.5 μm/y and GCIPL >1 μm/y demonstrate greater predictive power and are more clinically relevant for identifying individuals at high risk of both physical and cognitive disability progression outcomes. Further research is needed to standardize OCT thresholds and improve clinical use in treatment planning.</p>","PeriodicalId":19472,"journal":{"name":"Neurology® Neuroimmunology & Neuroinflammation","volume":"12 4","pages":"e200416"},"PeriodicalIF":7.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153945/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis.\",\"authors\":\"Nabil K El Ayoubi, Ali Ismail, Georgio Sader, Nour Abi Chakra, Jad El Ahdab, Joseph Abboud, Samia J Khoury\",\"doi\":\"10.1212/NXI.0000000000200416\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Optical coherence tomography (OCT) has emerged as a valuable marker for assessing inflammation and neuroaxonal degeneration in multiple sclerosis (MS). Although traditional markers such as brain atrophy and axonal loss are crucial for monitoring MS progression, their clinical application can be limited by various factors. This meta-analysis of longitudinal studies aims to assess the predictive value of OCT-derived retinal layer thickness thresholds for monitoring and predicting MS disease progression and cognitive decline.</p><p><strong>Methods: </strong>Our systematic review and meta-analysis followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A comprehensive systematic search was performed using electronic databases (PubMed, Embase, Web of Science, and Google Scholar) for longitudinal studies using Spectral Domain-OCT (SD-OCT) to assess retinal layer thickness and its predictive value for MS progression. Data were extracted on study design, OCT measurements, disability progression definitions, and clinical outcomes. We analyzed hazard ratios (HR) and odds ratios (OR) for associations between OCT-measured thresholds and disability progression, including physical and cognitive deterioration.</p><p><strong>Results: </strong>Our study included 14 longitudinal studies that met our inclusion criteria, 13 studies were included in our quantitative analysis, with a total of 3,683 participants. Baseline peripapillary retinal nerve fiber layer (pRNFL) thickness below 88 μm was significantly associated with increased risk of future disease progression and physical worsening measured by Expanded Disability Status Scale progression (HR = 2.376, <i>p</i> < 0.001; HR = 2.258, <i>p</i> < 0.001, respectively). The same was noted for ganglion cell-inner plexiform layer (GCIPL) thickness below 77 μm (HR = 2.751, <i>p</i> < 0.001 and HR = 2.66, <i>p</i> < 0.001, respectively). In addition, annualized rates of pRNFL thinning above 1.5 μm/y and GCIPL thinning above 1 μm/y also significantly predicted disease worsening (HR = 3.019, <i>p</i> = 0.005 and HR = 3.535, <i>p</i> < 0.001, respectively).</p><p><strong>Discussion: </strong>OCT-derived retinal layer thresholds, specifically a pRNFL thickness of ≤88 μm and a GCIPL thickness of ≤77 μm, are significantly associated with an increased risk of future MS disability progression. Furthermore, annual thinning rates of pRNFL >1.5 μm/y and GCIPL >1 μm/y demonstrate greater predictive power and are more clinically relevant for identifying individuals at high risk of both physical and cognitive disability progression outcomes. Further research is needed to standardize OCT thresholds and improve clinical use in treatment planning.</p>\",\"PeriodicalId\":19472,\"journal\":{\"name\":\"Neurology® Neuroimmunology & Neuroinflammation\",\"volume\":\"12 4\",\"pages\":\"e200416\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153945/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology® Neuroimmunology & Neuroinflammation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1212/NXI.0000000000200416\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology® Neuroimmunology & Neuroinflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXI.0000000000200416","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:光学相干断层扫描(OCT)已成为评估多发性硬化症(MS)炎症和神经轴突变性的一种有价值的标志物。尽管脑萎缩和轴突损失等传统标志物对监测MS进展至关重要,但它们的临床应用可能受到各种因素的限制。这项纵向研究的荟萃分析旨在评估oct衍生的视网膜层厚度阈值在监测和预测MS疾病进展和认知能力下降方面的预测价值。方法:我们的系统评价和荟萃分析遵循系统评价和荟萃分析指南的首选报告项目。利用电子数据库(PubMed, Embase, Web of Science和谷歌Scholar)进行了全面的系统搜索,使用光谱域oct (SD-OCT)进行纵向研究,以评估视网膜层厚度及其对MS进展的预测价值。数据包括研究设计、OCT测量、残疾进展定义和临床结果。我们分析了oct测量阈值与残疾进展(包括身体和认知恶化)之间的关联的风险比(HR)和优势比(OR)。结果:我们的研究包括14项符合我们纳入标准的纵向研究,13项研究被纳入我们的定量分析,总共有3,683名参与者。基线乳头周围视网膜神经纤维层(pRNFL)厚度低于88 μm与扩展残疾状态量表进展测量的未来疾病进展和身体恶化的风险增加显著相关(HR = 2.376, p < 0.001;HR = 2.258, p < 0.001)。对于厚度小于77 μm的神经节细胞-内丛状层(GCIPL), HR = 2.751, p < 0.001, HR = 2.66, p < 0.001。此外,pRNFL变薄大于1.5 μm/y和GCIPL变薄大于1 μm/y的年化率也能显著预测疾病恶化(HR = 3.019, p = 0.005和HR = 3.535, p < 0.001)。讨论:oct衍生的视网膜层阈值,特别是pRNFL厚度≤88 μm和GCIPL厚度≤77 μm,与未来MS残疾进展的风险增加显著相关。此外,pRNFL的年变薄率为1.5 μm/y, GCIPL的年变薄率为1 μm/y,具有更强的预测能力,在识别身体和认知残疾进展结果的高风险个体方面具有更大的临床相关性。规范OCT阈值,提高临床在治疗计划中的应用,需要进一步的研究。
Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis.
Background and objectives: Optical coherence tomography (OCT) has emerged as a valuable marker for assessing inflammation and neuroaxonal degeneration in multiple sclerosis (MS). Although traditional markers such as brain atrophy and axonal loss are crucial for monitoring MS progression, their clinical application can be limited by various factors. This meta-analysis of longitudinal studies aims to assess the predictive value of OCT-derived retinal layer thickness thresholds for monitoring and predicting MS disease progression and cognitive decline.
Methods: Our systematic review and meta-analysis followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A comprehensive systematic search was performed using electronic databases (PubMed, Embase, Web of Science, and Google Scholar) for longitudinal studies using Spectral Domain-OCT (SD-OCT) to assess retinal layer thickness and its predictive value for MS progression. Data were extracted on study design, OCT measurements, disability progression definitions, and clinical outcomes. We analyzed hazard ratios (HR) and odds ratios (OR) for associations between OCT-measured thresholds and disability progression, including physical and cognitive deterioration.
Results: Our study included 14 longitudinal studies that met our inclusion criteria, 13 studies were included in our quantitative analysis, with a total of 3,683 participants. Baseline peripapillary retinal nerve fiber layer (pRNFL) thickness below 88 μm was significantly associated with increased risk of future disease progression and physical worsening measured by Expanded Disability Status Scale progression (HR = 2.376, p < 0.001; HR = 2.258, p < 0.001, respectively). The same was noted for ganglion cell-inner plexiform layer (GCIPL) thickness below 77 μm (HR = 2.751, p < 0.001 and HR = 2.66, p < 0.001, respectively). In addition, annualized rates of pRNFL thinning above 1.5 μm/y and GCIPL thinning above 1 μm/y also significantly predicted disease worsening (HR = 3.019, p = 0.005 and HR = 3.535, p < 0.001, respectively).
Discussion: OCT-derived retinal layer thresholds, specifically a pRNFL thickness of ≤88 μm and a GCIPL thickness of ≤77 μm, are significantly associated with an increased risk of future MS disability progression. Furthermore, annual thinning rates of pRNFL >1.5 μm/y and GCIPL >1 μm/y demonstrate greater predictive power and are more clinically relevant for identifying individuals at high risk of both physical and cognitive disability progression outcomes. Further research is needed to standardize OCT thresholds and improve clinical use in treatment planning.
期刊介绍:
Neurology Neuroimmunology & Neuroinflammation is an official journal of the American Academy of Neurology. Neurology: Neuroimmunology & Neuroinflammation will be the premier peer-reviewed journal in neuroimmunology and neuroinflammation. This journal publishes rigorously peer-reviewed open-access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to) Alzheimer's disease, Parkinson's disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia gravis; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.